Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
WELLESLEY, Mass., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. ( Nasdaq: CLYM ) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio's Chair of its Board of Directors. Dr. Williams will assume the role of Chair of the Board, succeeding Andrew Levin, who will remain ...
| Ticker |
Sentiment |
Impact |
|
ACIU
|
Neutral
|
3 %
|
|
CDAKQ
|
Neutral
|
3 %
|
|
PFE
|
Neutral
|
3 %
|
|
BIIB
|
Neutral
|
7 %
|
|
BMY
|
Neutral
|
3 %
|
|
SANA
|
Neutral
|
3 %
|
